L’Oreal stock price: what to watch before Paris opens after Friday dip
18 January 2026
1 min read

L’Oreal stock price: what to watch before Paris opens after Friday dip

Paris, Jan 18, 2026, 21:54 CET — Market closed

  • On Friday, L’Oreal shares ended the day down 0.6%, closing at 384.85 euros.
  • A routine voting-rights filing showed up late in the session, as markets kept their eye on the overall risk sentiment.
  • Investors are eyeing the group’s annual results due mid-February for clues on the next move.

L’Oreal shares slipped on Friday, following the broader dip in European stocks ahead of the weekend.

The French cosmetics giant’s shares slipped 0.59%, ending at 384.85 euros on Euronext Paris, while the CAC 40 index dropped 0.65%. (MarketWatch)

Why it matters now: Europe’s rally is losing steam, with investors moving away from “buy the dip” toward demanding solid earnings as the season kicks off.

Mega-cap defensives such as L’Oreal find themselves in a tricky position. They tend to perform well when risk appetite drops, yet they face steep expectations after markets have already factored in a strong year.

Friday’s Reuters market wrap highlighted softness in luxury and mining stocks, while wider European shares hovered close to record highs. “The margin of safety that investors had previously is gone,” noted Morningstar strategist Michael Field. (Reuters)

L’Oreal’s move was modest, but the stock has shown volatility this month. So far this year, shares have swung between 355.65 euros and 396.90 euros. As of mid-January, the stock was up 6.72% since the start of the year, per the company’s market data page. (L’Oréal Finance)

Late in the week, L’Oreal filed its routine update on the total voting rights and shares outstanding as of Dec. 31, 2025. This standard regulatory disclosure in France confirms the number of shares and votes attached to them. (GlobeNewswire)

The filing seldom moves markets on its own. Yet, it arrives amid heightened scrutiny of ownership and governance among major European blue chips.

The bigger risk this week lies elsewhere: if the market mood shifts back to defensive, top-tier consumer stocks could be sold off to raise cash or simply because they’ve rallied too far.

The next major event to watch is earnings. According to L’Oreal’s financial calendar, the company will release its 2025 annual results on Feb. 12 after the market closes, with a financial information meeting set for Feb. 13. (L’Oréal Finance)

Stock Market Today

  • Medtronic advances into 2026 on diabetes spin-off, Hugo system, and steady dividends
    January 18, 2026, 4:43 PM EST. Medtronic (MDT) is trading on the prospect that a planned stand-alone spin-off of its diabetes business will sharpen focus on B2B operations and lift margins. Management has signaled the split should close by year-end 2026, reducing exposure to consumer diabetes care, which generated about 8% of revenue but only 4% of operating profit in fiscal 2025. A new growth driver comes from the Hugo robotic-assisted surgery (RAS) system, cleared in the U.S. for urologic procedures. While near-term top-line impact is modest, the device targets an underpenetrated market with long-term potential. Finally, Medtronic boasts a lengthy dividend streak, raising payouts for 48 consecutive years and offering about a 3% forward yield, with the potential to join the Dividend King club after 50 straight raises.
Novo Nordisk Class B stock jumps — Wegovy pill scripts and UK dose nod set up the week ahead
Previous Story

Novo Nordisk Class B stock jumps — Wegovy pill scripts and UK dose nod set up the week ahead

American Express stock rebounds before the long weekend as Trump’s rate-cap plan stays in play
Next Story

American Express stock rebounds before the long weekend as Trump’s rate-cap plan stays in play

Go toTop